Related Experiment Video
Updated: Jul 31, 2025

Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
Direct-to-Patient Clinical Trials: One Small Step or a Giant Leap?
Aakash Desai1, Vivek Subbiah2,3,4
1Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
Abstract:
Genome driven precision oncology has transformed the landscape of multiple cancers. However, access barriers exist. A recent study exemplified a direct-to-patient outreach program via social media through the implementation of a global program that offered free tumor genomic testing with a focus on rare cancers. See related article by Doe-Tetteh et al., p. 2445.
Insights
A global program offered free tumor genomic testing to patients via social media, overcoming access barriers for rare cancer genomic profiling. This initiative expanded precision oncology reach to underserved populations worldwide.
Area of Science:
- Oncology
- Genomics
- Genomic Medicine
Background:
- Precision oncology, driven by genomic profiling, has revolutionized cancer care.
- Significant access barriers limit the widespread application of genomic testing in oncology.
- Rare cancers often face even greater disparities in accessing advanced diagnostics.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blinding
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

